From: Gastrointestinal manifestations of synthetic cannabinoids: a retrospective cohort study
N (%) | GI symptoms (n = 21) | No GI symptoms (n = 34) |
---|---|---|
Male | 20 (95) | 29 (85) |
Hospitalized patients | 5 (24) | 9 (27) |
Median (IQR) | Â | Â |
Age | 28 (14) | 35 (21) |
Hospital attendances | 1 (2) | 1 (3) |
Duration of hospitalization* | 3 (4) | 8 (7) |